共 51 条
[1]
Luo M(2022)SARS-CoV-2 infection and liver involvement Hepatol Int. 16 755-774
[2]
Ballester MP(2023)Unraveling the molecular and cellular pathogenesis of COVID-19-associated liver injury Viruses. 15 1287-e10
[3]
Soffientini U(2023)Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update Arch Med Sci Atheroscler Dis. 8 e1-3047
[4]
Jalan R(2023)Liver damage and COVID-19: at least a "two-hit" story in systematic review Curr Issues Mol Biol. 45 3035-23
[5]
Mehta G(2023)SARS-CoV-2 infection and liver disease: a review of pathogenesis and outcomes Gut Liver. 17 12-577
[6]
Akkiz H(2021)Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study J Hepatol. 74 567-764
[7]
Miranda C(2023)Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic Hepatol Int. 42 762-218
[8]
Garlatti E(2022)Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA Liver Int. 366 209-194
[9]
Da Porto A(2023)Impact of COVID-19 pandemic on alcohol-related hepatitis admissions: analysis of nationwide data 2016–2020 Am J Med Sci. 5 e2245424-2666.e2662
[10]
Montori M(2022)Characteristics and treatment rate of patients with hepatitis C virus infection in the direct-acting antiviral era and during the COVID-19 pandemic in the United States JAMA Netw Open. 55 187-756